Takeda Pharmaceutical Co Ltd (TKPHF)
26.64
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Takeda Pharmaceutical Price to Book Value: 0.8698 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 17, 2024 | 0.8698 |
May 16, 2024 | 0.8698 |
May 15, 2024 | 0.8698 |
May 14, 2024 | 0.8496 |
May 13, 2024 | 0.876 |
May 10, 2024 | 0.876 |
May 09, 2024 | 0.876 |
May 08, 2024 | 0.8339 |
May 07, 2024 | 0.869 |
May 06, 2024 | 0.869 |
May 03, 2024 | 0.869 |
May 02, 2024 | 0.869 |
May 01, 2024 | 0.869 |
April 30, 2024 | 0.8507 |
April 29, 2024 | 0.8507 |
April 26, 2024 | 0.8507 |
April 25, 2024 | 0.8176 |
April 24, 2024 | 0.8414 |
April 23, 2024 | 0.8414 |
April 22, 2024 | 0.8414 |
April 19, 2024 | 0.8414 |
April 18, 2024 | 0.8659 |
April 17, 2024 | 0.8659 |
April 16, 2024 | 0.8659 |
April 15, 2024 | 0.8659 |
Date | Value |
---|---|
April 12, 2024 | 0.8659 |
April 11, 2024 | 0.8659 |
April 10, 2024 | 0.8659 |
April 09, 2024 | 0.8832 |
April 08, 2024 | 0.8682 |
April 05, 2024 | 0.8897 |
April 04, 2024 | 0.8627 |
April 03, 2024 | 0.8718 |
April 02, 2024 | 0.8718 |
April 01, 2024 | 0.9113 |
March 31, 2024 | |
March 28, 2024 | 0.9337 |
March 27, 2024 | 0.9337 |
March 26, 2024 | 0.9337 |
March 25, 2024 | 0.9337 |
March 22, 2024 | 0.9495 |
March 21, 2024 | 0.9495 |
March 20, 2024 | 0.9495 |
March 19, 2024 | 0.9495 |
March 18, 2024 | 0.9495 |
March 15, 2024 | 0.9495 |
March 14, 2024 | 0.9495 |
March 13, 2024 | 0.9656 |
March 12, 2024 | 0.9656 |
March 11, 2024 | 0.9737 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8176
Minimum
Apr 25 2024
1.452
Maximum
Nov 19 2019
1.092
Average
1.069
Median
Feb 10 2023
Price to Book Value Benchmarks
Nxera Pharma Co Ltd | 1.998 |
PeptiDream Inc | 5.887 |
Healios KK | 3.558 |
AnGes Inc | 0.4409 |
Price to Book Value Related Metrics
PE Ratio | 41.41 |
PS Ratio | 1.426 |
Price to Free Cash Flow | 25.80 |
Price | 26.64 |
Earnings Yield | 2.41% |
Market Cap | 41.80B |
Operating PE Ratio | 33.20 |
Normalized PE Ratio | 41.41 |